BOT 13.9% 37.0¢ botanix pharmaceuticals ltd

BOT - Anything but charting, page-7784

  1. 541 Posts.
    lightbulb Created with Sketch. 90
    Agree with you Savvy, IMHO: the Sofdra acquition was always to fund the trials, so the need for further dilution is negated.
 
watchlist Created with Sketch. Add BOT (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.